Tobacco smoking and HIV-related immunologic and virologic response among individuals of the Canadian HIV Observational Cohort (CANOC)

References

• Antiretroviral Therapy Cohort Collaboration. (2008). Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies. Lancet, 372(9635), 293–299. https://doi.org/10.1016/S0140-6736(08)61113-7
   PubMed Web of Science ®Google Scholar
• Arnsten, J., Demas, P., Grant, R., Gourevitch, M., Farzadegan, H., Howard, A., & Schoenbaum, E. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17(5), 377–381. https://doi.org/10.1007/s11606-002-0044-3
   PubMed Web of Science ®Google Scholar
• Bekele, T., Rueda, S., Gardner, S., Raboud, J., Smieja, M., Kennedy, R., Fletcher, D., Burchell, A. N., Bacon, J., & Rourke, S. B. (2017). Trends and correlates of cigarette smoking and its impacts on health-related quality of life among people living with HIV: Findings from the Ontario HIV treatment network cohort study, 2008-2014. AIDS Patient Care and STDs, 31(2), 49–59. https://doi.org/10.1089/apc.2016.0174
   PubMed Web of Science ®Google Scholar
• Burkhalter, J., Springer, C., Chhabra, R., Ostroff, J., & Rapkin, B. (2005). Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine & Tobacco Research, 7(4), 511–522. https://doi.org/10.1080/14622200500186064
   PubMed Web of Science ®Google Scholar
• Cropsey, K. L., Willig, J. H., Mugavero, M. J., Crane, H. M., McCullumsmith, C., Lawrence, S., Raper, J. L., Mathews, W. C., Boswell, S., Kitahata, M. M., Schumacher, J. E., Saag, M. S., & Systems, C. N. of I. C. (2016). Cigarette smokers are less likely to have undetectable viral loads: Results from four HIV clinics. Journal of Addiction Medicine, 10(1), 13–19. https://doi.org/10.1097/ADM.0000000000000172
   PubMed Web of Science ®Google Scholar
• Crothers, K., Griffith, T. A., McGinnis, K. A., Rodriguez-Barradas, M. C., Leaf, D. A., Weissman, S., Gibert, C. L., Butt, A. A., & Justice, A. C. (2005). The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. Journal of General Internal Medicine, 20(12), 1142–1145. https://doi.org/10.1111/j.1525-1497.2005.0255.x
   PubMed Web of Science ®Google Scholar
• Feldman, D. N., Feldman, J. G., Greenblatt, R., Anastos, K., Pearce, L., Cohen, M., Gange, S., Leanza, S., & Burk, R. (2009). CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women. AIDS Education and Prevention, 21(S3), 81–93. https://doi.org/10.1521/aeap.2009.21.3_supp.81
   PubMedGoogle Scholar
• Feldman, J. G., Minkoff, H., Schneider, M. F., Gange, S. J., Cohen, M., Watts, D. H., Gandhi, M., Mocharnuk, R. S., & Anastos, K. (2006). Association of cigarette smoking with HIV prognosis among women in the HAART era: A report from the women’s interagency HIV study. American Journal of Public Health, 96(6), 1060–1065. https://doi.org/10.2105/AJPH.2005.062745
   PubMed Web of Science ®Google Scholar
• Frazier, E., Sutton, M., Brooks, J., Shouse, R., & W, J. (2018). Trends in cigarette smoking among adults with HIV compared with the general adult population, United States - 2009–2014. Preventative Medicine, 111, 231–234. https://doi.org/10.1016/j.ypmed.2018.03.007
   PubMed Web of Science ®Google Scholar
• Gilson, R., Man, S.-L., Copas, A., Rider, A., Forsyth, S., Hill, T., Bansi, L., Porter, K., Gazzard, B., Orkin, C., Pillay, D., Schwenk, A., Johnson, M., Easterbook, P., Walsh, J., Fisher, M., Leen, C., Anderson, J., Sabin, C. A., & Group, U. C. H. C. S. (2010). Discordant responses on starting highly active antiretroviral therapy: Suboptimal CD4 increases despite early viral suppression in the UK collaborative HIV cohort (UK CHIC) study. HIV Medicine, 11(2), 152–160. https://doi.org/10.1111/j.1468-1293.2009.00755.x
   PubMed Web of Science ®Google Scholar
• Grabar, S., Moing, V., Goujard, C., Leport, C., Kazatchkine, M., Costagliola, D., & Weiss, L. (2000). Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Annals of Internal Medicine, 133(6), 401–410. https://doi.org/10.7326/0003-4819-133-6-200009190-00007
   PubMed Web of Science ®Google Scholar
• Helleberg, M., Afzal, S., Kronborg, G., Larsen, C. S., Pedersen, G., Pedersen, C., Gerstoft, J., Nordestgaard, B. G., & Obel, N. (2013). Mortality attributable to smoking among HIV-1-infected individuals: A nationwide, population-based cohort study. Clinical Infectious Diseases, 56(5), 727–734. https://doi.org/10.1093/cid/cis933
   PubMed Web of Science ®Google Scholar
• Hile, S., Feldman, M., Alexy, E., & Irvine, M. (2016). Recent tobacco smoking is associated with poor HIV Medical outcomes Among HIV-infected individuals in New York. AIDS and Behavior, 20(8), 1722–1729. https://doi.org/10.1007/s10461-015-1273-x
   PubMed Web of Science ®Google Scholar
• Hiscock, R., Bauld, L., Amos, A., Fidler, J., & Munafo, M. (2012). Socioeconomic status and smoking: A review. Annals of the New York Academy of Sciences, 1248(1), 107–123. https://doi.org/10.1111/j.1749-6632.2011.06202.x
   PubMed Web of Science ®Google Scholar
• Kabali, C., Cheng, D., Brooks, D., Bridden, C., Horsburgh Jr, R., & Samet, J. (2011). Recent cigarette smoking and HIV disease progression: No evidence of an association. AIDS Care, 23(8), 947–956. https://doi.org/10.1080/09540121.2010.542128
   PubMed Web of Science ®Google Scholar
• Kelly, C., Gaskell, K., Richardson, M., Klein, N., Garner, P., & MacPherson, P. (2016). Discordant immune response with antiretroviral therapy in HIV-1: A systematic review of clinical outcomes. PLoS ONE, 11(6), e0156099. https://doi.org/10.1371/journal.pone.0156099
   Google Scholar
• Lichtenstein, K. A., Armon, C., Buchacz, K., Chmiel, J. S., Buckner, K., Tedaldi, E M, Wood, K., Holmberg, S. D., Brooks, J. T., & Investigators, H. O. S. (2010). Lower CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clinical Infectious Diseases, 51(4), 435–447. https://doi.org/10.1086/655144
   PubMed Web of Science ®Google Scholar
• Lofters, A. K, McBride, M. L, Li, D., Whitehead, M, Moineddin, R., Jiang, L, Grunfeld, E., & Groome, P. A. (2019). Disparities in breast cancer diagnosis for immigrant women in Ontario and BC: results from the CanIMPACT study. BMC Cancer, 19(1). https://doi.org/10.1186/s12885-018-5201-0
   Google Scholar
• Montaner, J. S. G., Lima, V. D., Harrigan, P. R., Lourenço, L., Yip, B., Nosyk, B., Wood, E., Kerr, T., Shannon, K., Moore, D., Hogg, R. S., Barrios, R., Gilbert, M., Krajden, M., Gustafson, R., Daly, P., Kendall, P., & Sluis-Cremer, N. (2014). Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: The “HIV Treatment as prevention” experience in a Canadian setting. PLoS ONE, 9(2), article no. e87872. https://doi.org/10.1371/journal.pone.0087872
   Google Scholar
• Moore, D., Hogg, R., Yip, B., Wood, E., Tyndall, M., Braitstein, P., & Montaner, J. (2005). Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor aderence to therapy. Journal of Acquired Immune Deficiency Syndrome, 40(3), 288–293. https://doi.org/10.1097/01.qai.0000182847.38098.d1
   PubMed Web of Science ®Google Scholar
• Nagelhout, G., de Korte-de Boer, D., Kunst, A., van der Meer, R., de Vries, H., van Gelder, B., & Willemsen, M. (2012). Trends in socioeconomic inequalities in smoking prevalence, consumption, initiation, and cessation between 2001 and 2008 in the Netherlands. Findings from a national population survey. BMC Public Health, 12(1), 303. https://doi.org/10.1186/1471-2458-12-303
   PubMedGoogle Scholar
• O’Cleirigh, C., Valentine, S., Pinkston, M., Herman, D., Bedoya, C., Gordon, J., & Safren, S. (2015). The unique challenges facing HIV-infected patients who smoke cigarettes: HIV viremia, ART adherence, engagement in HIV care, and concurrent substance use. AIDS and Behavior, 19(1), 178–185. https://doi.org/10.1007/s10461-014-0762-7
   PubMed Web of Science ®Google Scholar
• Palmer, A. K., Klein, M. B., Raboud, J., Cooper, C., Hosein, S., Loutfy, M., Machouf, N., Montaner, J., Rourke, S. B., Smieja, M., Tsoukas, C., Yip, B., Milan, D., & Hogg, R. S. (2011). Cohort profile: The Canadian Observational Cohort collaboration. International Journal of Epidemiology, 40(1), 25–32. https://doi.org/10.1093/ije/dyp393
   PubMed Web of Science ®Google Scholar
• Pampalon, R., Hamel, D., Gamache, P., & Raymond, G. (2009). A deprivation index for health planning in Canada. Chronic Diseases in Canada, 29(4), 178–191. https://doi.org/10.24095/hpcdp.29.4.05
   PubMed Web of Science ®Google Scholar
• Piketty, C., Weiss, L., Thomas, F., Mohamed, A., Belec, L., & Kazatchkine, M. (2001). Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen. The Journal of Infectious Diseases, 183(9), 1328–1335. https://doi.org/10.1086/319861
   PubMed Web of Science ®Google Scholar
• Pines, H., Koutsky, L., & Buskin, S. (2011). Cigarette smoking and mortality among HIV-infected individuals in Seattle, Washington (1996-2008). AIDS and Behavior, 15(1), 243–251. https://doi.org/10.1007/s10461-010-9682-3
   PubMed Web of Science ®Google Scholar
• Shirley, D., Kaner, R., & Glesby, M. (2013). Effects of smoking on non-AIDS-related morbidity in HIV-infected patients. Clinical Infectious Diseases, 57(2), 275–282. https://doi.org/10.1093/cid/cit207
   PubMed Web of Science ®Google Scholar
• Shuter, J., & Bernstein, S. (2008). Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine & Tobacco Research, 10(4), 731–736. https://doi.org/10.1080/14622200801908190
   PubMed Web of Science ®Google Scholar
• Tan, R., Westfall, A., Willig, J., Mugavero, M., Saag, M., Kaslow, R., & Kempf, M. (2008). Clinical outcomes of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 47(5), 553–558. https://doi.org/10.1097/QAI.0b013e31816856c5
   PubMed Web of Science ®Google Scholar
• Webb, M., Vanable, P., Carey, M., & Blair, D. (2007). Cigarette smoking among HIV+ Men and women: Examining health, substance Use, and psychosocial correlates across the smoking spectrum. Journal of Behavioral Medicine, 30(5), 371–383. https://doi.org/10.1007/s10865-007-9112-9
   PubMed Web of Science ®Google Scholar
• Winhusen, T., Feaster, D., Duan, R., Brown, J., Daar, E., Mandler, R., & Metsch, L. (2018). Baseline cigarette smoking status as a predictor of virologic suppression and CD4 cell count during one-year follow-up in substance users with uncontrolled HIV infection. AIDS and Behavior, 22(6), 2026–2032. https://doi.org/10.1007/s10461-017-1928-x
   PubMed Web of Science ®Google Scholar